In this study, we show that CTL-mediated immune pressure confers resistance to ferroptosis in tumor cells through transcriptional induction of HMGCR by E2F1, thereby could contribute to refractory phenotypes to T cell-based therapies. This evidence concerns the gene HMGCR and neoplasm.